Relmada Therapeutics Inc (NAS:RLMD)
$ 3.475 -0.005 (-0.14%) Market Cap: 104.86 Mil Enterprise Value: 34.57 Mil PE Ratio: 0 PB Ratio: 1.70 GF Score: 34/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1